Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dental Pulp Stem Cells Differentiation Into Retinal Ganglion-Like Cells in a Three Dimensional Network Publisher Pubmed



Roozafzoon R1, 2 ; Lashay A2 ; Vasei M1 ; Ai J1 ; Khoshzaban A2, 3 ; Keshel SH2 ; Barabadi Z1 ; Bahrami H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Stem Cell Preparation Unit, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. BioDental Materials Department, Dental Faculty of Tehran University of Medical Sciences, Tehran, Iran

Source: Biochemical and Biophysical Research Communications Published:2015


Abstract

The loss of retinal ganglion cells (RGCs) in majority of retinal degenerative diseases is the first seen pathological event. A lot of studies aim to discover suitable cell sources to replace lost and damaged RGCs. Among them dental pulp stem cells (DPSCs) have a great potential of differentiating into neuronal lineages as well as RGCs. Moreover, three-dimensional (3D) networks and its distribution for growing and differentiation of stem cells as much as possible mimic to native tissue holds great potential in retinal tissue engineering. In this study, we isolate DPSCs from rat incisors and validate them with flow cytometry. Briefly, we differentiated cells using DMEM/F12 containing FGF2, Shh and 0.5% FBS into retinal ganglion-like cells (RGLCs) in two conditions; 3D state in biocompatible fibrin hydrogel and two-dimensional (2D) or conventional culture in polystyrene plates. Immuncytochemical and gene expression analysis revealed the expression of Pax6, Atoh7 and BRN3B increased in 3D fibrin culture compared to 2D conventional culture. In combination, these data demonstrate that using 3D networks can resemble near natural tissue properties for effective generating RGCs which used to treat neurodegenerative diseases such as glaucoma. © 2014 Elsevier Inc. All rights reserved.